SPY302.97-0.56 -0.18%
DIA254.35-1.42 -0.56%
IXIC9,368.99-43.37 -0.46%

Sunesis Pharmaceuticals Q1 EPS $(0.050) Beats $(0.070) Estimate, Sales $120.000K Miss $190.000K Estimate

Sunesis Pharmaceuticals (NASDAQ:SNSS) reported quarterly losses of $(0.050) per share which beat the analyst consensus estimate of $(0.070) by 28.57 percent. This is a 50 percent increase over losses of $(0.100) per

Benzinga · 05/07/2020 20:55

Sunesis Pharmaceuticals (NASDAQ:SNSS) reported quarterly losses of $(0.050) per share which beat the analyst consensus estimate of $(0.070) by 28.57 percent. This is a 50 percent increase over losses of $(0.100) per share from the same period last year. The company reported quarterly sales of $120.000 thousand which missed the analyst consensus estimate of $190.000 thousand by 36.84 percent.